HK1093757A1 - Diagnostic for osteoporosis - Google Patents

Diagnostic for osteoporosis

Info

Publication number
HK1093757A1
HK1093757A1 HK07100634.5A HK07100634A HK1093757A1 HK 1093757 A1 HK1093757 A1 HK 1093757A1 HK 07100634 A HK07100634 A HK 07100634A HK 1093757 A1 HK1093757 A1 HK 1093757A1
Authority
HK
Hong Kong
Prior art keywords
osteoporosis
diagnostic
haplotype
therapeutics
diagnostics
Prior art date
Application number
HK07100634.5A
Other languages
English (en)
Inventor
Kenneth Kornman
Paul M Martha
Gordon W Duff
Simon Van Dijk
Original Assignee
Interleukin Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interleukin Genetics Inc filed Critical Interleukin Genetics Inc
Publication of HK1093757A1 publication Critical patent/HK1093757A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK07100634.5A 2003-08-08 2007-01-18 Diagnostic for osteoporosis HK1093757A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49386103P 2003-08-08 2003-08-08
PCT/US2004/025858 WO2005013809A2 (en) 2003-08-08 2004-08-09 Diagnostic and therapeutics for osteoporosis

Publications (1)

Publication Number Publication Date
HK1093757A1 true HK1093757A1 (en) 2007-03-09

Family

ID=34135292

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07100634.5A HK1093757A1 (en) 2003-08-08 2007-01-18 Diagnostic for osteoporosis

Country Status (11)

Country Link
US (1) US7723028B2 (xx)
EP (1) EP1680513B1 (xx)
JP (1) JP2007501627A (xx)
KR (1) KR20060061350A (xx)
CN (1) CN1863928A (xx)
AT (1) ATE490339T1 (xx)
AU (1) AU2004263184B2 (xx)
CA (1) CA2534365A1 (xx)
DE (1) DE602004030367D1 (xx)
HK (1) HK1093757A1 (xx)
WO (1) WO2005013809A2 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090023147A1 (en) * 1999-08-30 2009-01-22 Kenneth Kornman Diagnostics and therapeutics for osteoporosis
US20070264645A1 (en) * 2002-01-25 2007-11-15 Kenneth Kornman IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes
ATE490339T1 (de) 2003-08-08 2010-12-15 Interleukin Genetics Inc Diagnostikum für osteoporose
EP1951903A2 (en) * 2005-10-25 2008-08-06 Interleukin Genetics, Inc. The il-1 gene cluster and associated inflammatory polymorphisms and haplotypes
WO2008060627A2 (en) * 2006-11-15 2008-05-22 Interleukin Genetics, Inc. The il-1 gene cluster, insulin resistance and coronary artery disease associated polymorphisms and haplotypes and methods of using same
KR100909709B1 (ko) * 2007-03-30 2009-07-30 대한민국 골밀도 및 골절 위험과 ｉｔｇａ１ 유전자 다형성과의연관성
US20100112570A1 (en) * 2008-10-22 2010-05-06 Interleukin Genetics, Inc. Genetic Markers for Weight Management and Methods of Use Thereof
WO2010083294A2 (en) * 2009-01-16 2010-07-22 Interleukin Genetics, Inc. Diagnostics and therapeutics for osteoporosis
AU2017207341A1 (en) 2016-01-12 2018-08-02 Interleukin Genetics, Inc. Methods for predicting response to treatment
US10337070B2 (en) 2017-01-12 2019-07-02 Cardioforecast Ltd. Methods and kits for treating cardiovascular disease
WO2020245402A1 (en) 2019-06-06 2020-12-10 Cardioforecast Ltd Compositions and methods for treating lung, colorectal and breast cancer
WO2021028469A1 (en) 2019-08-12 2021-02-18 Sitokine Limited Compositions and methods for treating cytokine release syndrome and neurotoxicity
WO2021205013A1 (en) 2020-04-09 2021-10-14 Sitokine Limited Compositions and methods for treating covid-19

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8311018D0 (en) * 1983-04-22 1983-05-25 Amersham Int Plc Detecting mutations in dna
US4833080A (en) * 1985-12-12 1989-05-23 President And Fellows Of Harvard College Regulation of eucaryotic gene expression
US4998617A (en) * 1986-09-15 1991-03-12 Laura Lupton Inc Facial cosmetic liquid make up kit
CA1316520C (en) 1987-05-19 1993-04-20 Larry C. Hamilton Valve
US4968607A (en) * 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5459039A (en) * 1989-05-12 1995-10-17 Duke University Methods for mapping genetic mutations
FR2650840B1 (fr) 1989-08-11 1991-11-29 Bertin & Cie Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications
US6004744A (en) 1991-03-05 1999-12-21 Molecular Tool, Inc. Method for determining nucleotide identity through extension of immobilized primer
WO1992015694A1 (en) 1991-03-08 1992-09-17 The Salk Institute For Biological Studies Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor
WO1993011149A1 (en) 1991-12-03 1993-06-10 Thomas Jefferson University Methods of detecting a genetic predisposition for osteoporosis
DK0652975T3 (da) 1992-07-31 2005-02-14 Garvan Inst Med Res Vurdering af allelvariation med hensyn til trans-virkende faktorer
JP3472587B2 (ja) 1992-08-28 2003-12-02 アベンティス ファーマ株式会社 骨関連カルボキシペプチダーゼ様タンパク質およびその製造法
CA2152667C (en) 1992-12-28 2003-02-11 David J. Baylink Bone resorption assay
US5547835A (en) 1993-01-07 1996-08-20 Sequenom, Inc. DNA sequencing by mass spectrometry
IL108947A0 (en) 1993-03-12 1994-06-24 Osteopharm Ltd Bone stimulating factor
US5593826A (en) * 1993-03-22 1997-01-14 Perkin-Elmer Corporation, Applied Biosystems, Inc. Enzymatic ligation of 3'amino-substituted oligonucleotides
CA2164498C (en) 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
US5686246A (en) * 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
US5942390A (en) 1996-01-12 1999-08-24 Cedars-Sinai Medical Center Method of diagnosing predisposition for ulcerative colitis in Jewish population by detection of interleukin-1 receptor antagonist polymorphism
US5698399A (en) * 1996-04-05 1997-12-16 Duff; Gordon W. Detecting genetic predisposition for osteoporosis
GB9621129D0 (en) * 1996-10-10 1996-11-27 Duff Gordon W Detecting genetic predisposition to sight-threatening diabetic retinopathy
GB9706359D0 (en) 1997-03-27 1997-05-14 Gemini International Holdings Polymorphisms of an il-1 receptor antagonist gene
GB9711040D0 (en) * 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease
JP2004504802A (ja) 1999-08-30 2004-02-19 インターロイキン・ジェネティクス・インコーポレーテッド 骨粗鬆症の診断および療法
JP2002345500A (ja) * 2000-12-22 2002-12-03 Pfizer Prod Inc 炎症性障害を発展させる増加したリスクを検出するための方法および試薬
KR20040026665A (ko) * 2001-06-15 2004-03-31 인터레우킨 제네틱스, 인코포레이티드 노화 관련 증상의 조기 개시를 검출 및 치료하는 방법
ATE490339T1 (de) 2003-08-08 2010-12-15 Interleukin Genetics Inc Diagnostikum für osteoporose

Also Published As

Publication number Publication date
CA2534365A1 (en) 2005-02-17
WO2005013809A2 (en) 2005-02-17
EP1680513B1 (en) 2010-12-01
AU2004263184A1 (en) 2005-02-17
EP1680513A2 (en) 2006-07-19
ATE490339T1 (de) 2010-12-15
EP1680513A4 (en) 2006-11-08
WO2005013809A3 (en) 2006-01-12
KR20060061350A (ko) 2006-06-07
CN1863928A (zh) 2006-11-15
AU2004263184B2 (en) 2010-12-02
US7723028B2 (en) 2010-05-25
DE602004030367D1 (de) 2011-01-13
US20050084882A1 (en) 2005-04-21
JP2007501627A (ja) 2007-02-01

Similar Documents

Publication Publication Date Title
HK1093757A1 (en) Diagnostic for osteoporosis
GB0418542D0 (en) Integrated biosensor and simulation system for diagnosis and therapy
AP2005003463A0 (en) Modified-release tablet of bupropion hydrochloride.
WO2006020269A3 (en) Biomarkers of neurodegenerative disease
EP1806581A4 (en) SYSTEM FOR DIAGNOSING A DISEASE
EP1694816A4 (en) BIOMARKERS FOR ALZHEIMER BIOMARKERS DISEASE FOR ALZHEIMER'S DISEASE
WO2004060302A3 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
DE602004031818D1 (de) Halbkugelförmiges Ventil für eine medizinische Vorrichtung
BR0014150A (pt) Diagnósticos e terapêuticos para osteoporose
WO2006046270A3 (en) Nucleophosmin protein (npm) mutants, corresponding gene sequences and uses thereof
ZA200603178B (en) Quick test for the diagnosis of Alzheimer's disease
WO2006104761A3 (en) Unique sequence hybridization probes (usp)
FI20010323A0 (fi) Diagnostinen geenitesti
ITMI20030479A1 (it) Procedimento per la preparazione di un ciano-isobenzofurano.
ITRM20030283A1 (it) Mezzi terapeutici e diagnostici per i papillomi.
ITVI20030053A1 (it) Blocchetto indicatore.
Petersen et al. La Belle Alliance: Violin/Piano Duo (Program)
GB0304617D0 (en) Diagnostic instrument
ITVI20030128A1 (it) Blocchetto indicatore.
ITCZ20030008A1 (it) Apparecchiatura per diagnostica sanitaria elettroepidermica.
ES1052417Y (es) Amasadora facilmente desmontable.
GB0300013D0 (en) Instant step rescue (I.S.R)
ITUD20030080A1 (it) Procedimento per effettuare transazioni commerciali.
GB0323523D0 (en) The S.A.S surgical instrument
BR8302055Y1 (pt) aperfeiÇoamento em diafragma para estetoscàpios.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140809